People who have lost weight on GLP-1 drugs such as Ozempic, Wegovy, and Zepbound should perform a six-minute strength workout every day to preserve muscle. This advice comes from biologist and longevity expert Gary Brecka of Miami, Florida, in an interview with Fox News.
According to Gallup, 11 percent of American adults report using these drugs for weight loss. In 2024, the figure was 3 percent. Brecka explains that lean mass accounts for roughly 20–40 percent of the weight lost on these drugs. Lean mass includes not only muscle but also water, organs, blood, tendons, and ligaments. That is why losing lean mass matters for the body's overall health, not just its appearance.
As the core strategy, the expert recommends starting with six minutes of daily resistance exercises combined with adequate protein intake. The federal guideline calls for 1.2–1.6 grams of protein per kilogram of body weight per day. Strength exercises should be done at least three days a week, with cardio on another three days. Brecka suggests bodyweight exercises, including planks, squats, and crunches, as well as squats with dumbbells or a kettlebell. For cardio, he recommends walking, stair climbing, and weighted vests.
At the same time, Brecka stresses that the six-minute routine is his own strategy, not the result of a scientific study. He also urges patients to tell their doctors if they notice a drop in energy or a decline in physical endurance while taking the medication. Such symptoms may indicate problems that should be discussed with a physician before changing treatment or exercise routines.
This roundup also mentions blogger Supper Mario Broth, an author who has been writing about Nintendo games since 2012 and has about 270,000 followers on X. He publishes facts about Mario, and his blog has been running for over ten years. He says he lives with heart failure and a genetic condition that affects his vision. The blogger estimates his chances of surviving one year at roughly two in three. His eyesight is deteriorating, and it is unknown whether surgery or medication could slow this process. He promises to keep publishing as long as his physical condition allows, though there may be gaps in his content.